Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 24
Filter
1.
Am J Clin Pathol ; 161(1): 42-48, 2024 Jan 04.
Article in English | MEDLINE | ID: mdl-37658808

ABSTRACT

OBJECTIVES: To assess the utility and performance of the large language model ChatGPT 4.0 regarding accuracy, completeness, and its potential as a time-saving tool for pathologists and laboratory directors. METHODS: A deidentified database of questions previously sent to pathology residents from health care providers was used as a source of general knowledge-type pathology questions. These questions were submitted to the large language model and the responses graded by subject matter experts in different pathology subspecialties. The grading criteria assessed accuracy, completeness, and the potential time savings for helping the pathologist craft the response. RESULTS: Overall, respondents thought that most of the answers would take less than 5 minutes of additional work to be used (85%). Accuracy and completeness for the 61 questions was high, with 98% of responses being at least "completely or mostly accurate" and 82% of responses "containing all relevant information." Of the respondents, 97% stated that the response would have "zero or near-zero potential for medical harm," and all thought the tool had potential to save time in constructing answers to health care providers' queries. Performance was similar in both Anatomic Pathology (AP) and Clinical Pathology (CP), with the only exception being some relevant information was excluded in 46% of AP answers vs only 10% in CP (P < .01). CONCLUSIONS: ChatGPT version 4.0 gave responses that were predominantly accurate and complete for general knowledge-type pathology questions. With further research and when reviewed by a pathologist or laboratorian, this could facilitate its use as a pathologist's aid in answering questions from health care providers.


Subject(s)
Pathologists , Pathology, Clinical , Humans , Databases, Factual , Health Personnel , Language
3.
Gynecol Oncol Rep ; 32: 100525, 2020 May.
Article in English | MEDLINE | ID: mdl-32181315

ABSTRACT

•Cervical Mullerian adenosarcoma is a tumor that affects reproductively aged women.•Hysterectomy had been the standard of care for these premenopausal women.•This case reports the most minimally invasive approach with no recurrence.•Accurate pathology interpretation is essential to diagnose and treat patients.•This is a rare tumor that if misdiagnosed or mischaracterized could be lethal.

4.
Appl Immunohistochem Mol Morphol ; 28(3): e26-e30, 2020 03.
Article in English | MEDLINE | ID: mdl-32167968

ABSTRACT

Lynch syndrome is an autosomal dominant disorder, caused by an abnormality in DNA mismatch repair genes and characterized by the development of a variety of cancers. Upper urinary tract urothelial carcinoma is well characterized in Lynch syndrome; however, support for the inclusion of bladder urothelial carcinoma is limited, except for MSH2 mutation carriers. Urologic adenocarcinoma has not been documented in Lynch syndrome. Here we report, to the best of our knowledge, the first case of bladder adenocarcinoma, synchronous with uterine endometrioid dedifferentiated endometrioid adenocarcinoma in a patient with Lynch syndrome. We present a 47-year-old woman with an MLH1 gene mutation (G133X 397G>T) who presented with menorrhagia. Eleven family members have this mutation, 6 with carcinoma: 5 colorectal and 1 with a gynecologic primary of unknown type. Colonoscopy and endoscopy were unremarkable. Positron emission and computed tomography revealed a 3 cm anterior dome bladder mass without additional extrauterine disease or uterine connection. She underwent partial cystectomy, laparoscopic hysterectomy, bilateral salpingo-oophorectomy, and lymphadenectomy. The uterus demonstrated a dedifferentiated endometrioid adenocarcinoma, immunohistochemically positive for vimentin, ER, CK7, MSH2, MSH6, and p53 (focally) and negative for CEA, CDX2, CK20, ß-catenin, MLH1, and PMS2. The bladder demonstrated a well-differentiated, enteric-type adenocarcinoma without muscularis propria invasion, positive for CEA, CDX2, CK20, p53, MSH2, and MSH6 and negative for vimentin, ER, CK7, MLH1, and PMS2. Eleven nodes were negative for carcinoma. The morphologic, immunohistochemical, and clinical findings support synchronous bladder adenocarcinoma, enteric type, and uterine dedifferentiated endometrioid adenocarcinoma, in a patient with Lynch syndrome.


Subject(s)
Adenocarcinoma , Carcinoma, Endometrioid , Colorectal Neoplasms, Hereditary Nonpolyposis , Endometrial Neoplasms , MutL Protein Homolog 1 , Mutation, Missense , Neoplasm Proteins , Neoplasms, Second Primary , Urinary Bladder Neoplasms , Adenocarcinoma/diagnostic imaging , Adenocarcinoma/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/surgery , Amino Acid Substitution , Carcinoma, Endometrioid/diagnostic imaging , Carcinoma, Endometrioid/genetics , Carcinoma, Endometrioid/metabolism , Carcinoma, Endometrioid/surgery , Colorectal Neoplasms, Hereditary Nonpolyposis/diagnostic imaging , Colorectal Neoplasms, Hereditary Nonpolyposis/genetics , Colorectal Neoplasms, Hereditary Nonpolyposis/surgery , Endometrial Neoplasms/diagnostic imaging , Endometrial Neoplasms/genetics , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/surgery , Female , Humans , Middle Aged , MutL Protein Homolog 1/genetics , MutL Protein Homolog 1/metabolism , Neoplasm Proteins/genetics , Neoplasm Proteins/metabolism , Neoplasms, Second Primary/diagnostic imaging , Neoplasms, Second Primary/genetics , Neoplasms, Second Primary/metabolism , Neoplasms, Second Primary/surgery , Urinary Bladder Neoplasms/diagnostic imaging , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/surgery
5.
Pathol Res Pract ; 216(4): 152863, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32098697

ABSTRACT

Cervical cancer continues to be a prevalent diagnosis among gynecologic pathology despite widespread screening methods and known pathogenesis by human papilloma virus. We describe a patient who underwent next generation sequencing (NGS) of her high grade squamous dysplasia (HG-SIL) as well as the invasive component of her cervical cancer. This tumor showed an amplification of PIK3CA in the invasive carcinoma in addition to a common E542K mutation both in dysplastic and invasive carcinoma. The dysplasia also showed a novel PCNX (e1) - RAD51B (e8) fusion suggesting potentially new mechanisms of pathogenesis in cervical squamous cell carcinoma.


Subject(s)
Carcinoma, Squamous Cell/genetics , Uterine Cervical Neoplasms/genetics , Adult , Class I Phosphatidylinositol 3-Kinases/genetics , DNA-Binding Proteins/genetics , Female , High-Throughput Nucleotide Sequencing , Humans , Neoplasm Proteins/genetics , Oncogene Proteins, Fusion/genetics
7.
Int Wound J ; 16(6): 1445-1449, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31531925

ABSTRACT

Amelanotic melanoma is a rare melanoma subtype, and it is even more rare when it occurs at an acral site. We here present a case of a nodular amelanotic acral melanoma (NAAM) occurring on the heel of an 83-year old female. It presented as an ulcerated pink nodular growth on the heel, which clinically mimicked other nodular non-pigmented lesions, causing a delay in diagnosis until it was biopsied. This case is a demonstration of the critical importance to include NAAM in the differential diagnosis of nodular non-pigmented skin lesions as to avoid delay in diagnosis and disease progression, in which early detection can provide the most modifiable prognostic factor.


Subject(s)
Melanoma, Amelanotic/pathology , Skin Neoplasms/pathology , Adipose Tissue/pathology , Aged, 80 and over , Delayed Diagnosis , Female , Heel , Humans , Neoplasm Invasiveness
8.
J Hand Surg Am ; 44(1): 70.e1-70.e5, 2019 Jan.
Article in English | MEDLINE | ID: mdl-29678430

ABSTRACT

Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy, is a rare entity in which bone involvement occurs in less than 5% to 10% of patients and skeletal cases are usually multifocal. Extranodal solitary lesions of bone without nodal involvement or additional clinical manifestations are exceedingly rare. We present the clinical course and management of a 34-year-old African American woman who presented with the disease as a solitary lesion of the distal radius.


Subject(s)
Histiocytosis, Sinus/diagnostic imaging , Histiocytosis, Sinus/surgery , Radius/diagnostic imaging , Radius/surgery , Adult , Female , Humans , Magnetic Resonance Imaging , Radiography
11.
Appl Immunohistochem Mol Morphol ; 25(5): e30-e33, 2017.
Article in English | MEDLINE | ID: mdl-27299190

ABSTRACT

Follicular dendritic cell (FDC) sarcoma is a rare neoplasm that occurs predominantly in lymph nodes. One third of FDC sarcomas happens in extranodal sites. There are 2 morphologic variants of this tumor: conventional and inflammatory pseudotumor (IPT)-like. IPT-like FDC sarcomas are reported mostly in females and usually involve the spleen and liver. In all cases of IPT-like FDC sarcoma the Epstein-Barr virus (EBV) was positive by in situ hybridization except one instance. We report a case of 53-year-old woman who presented with abdominal discomfort. Colonoscopy identified a sessile polypoid mass. Microscopically, there was a prominent lymphoplasmacytic infiltrate. Interspersed among the reactive lymphoid cells were large, pleomorphic stromal cells with marked atypia, irregular and multilobed nuclei, and hyperchromatic smudged chromatin. Immunohistochemical studies demonstrated the atypical stromal cells to be strongly positive for CD10 and D2-40, but negative for CD21, CD23, Clusterin, and epidermal growth factor receptor. EBV-encoded mRNA was negative. A diagnosis of IPT-like FDC sarcoma was rendered. To our knowledge, this is the second case of EBV-negative IPT-like FDC sarcoma reported so far in the literature.


Subject(s)
Colonic Neoplasms/diagnosis , Colonic Neoplasms/pathology , Dendritic Cell Sarcoma, Follicular/diagnosis , Dendritic Cell Sarcoma, Follicular/pathology , Antigens, Viral/analysis , Antigens, Viral/genetics , Colonic Neoplasms/virology , Dendritic Cell Sarcoma, Follicular/virology , Female , Herpesvirus 4, Human/genetics , Humans , Inflammation/etiology , Middle Aged
13.
Radiol Case Rep ; 12(4): 811-814, 2017 Dec.
Article in English | MEDLINE | ID: mdl-29484077

ABSTRACT

Liposarcomas are classified into 4 different subtypes, with the myxoid-round cell variant demonstrating increased morbidity and metastatic potential dependent on cell composition. Unique to sarcomas, the myxoid-round cell liposarcoma is remarkably sensitive to radiation therapy in the pretreatment setting, owing to the tumor morphology and vascular distribution. Herein we report a case of myxoid-round cell liposarcoma within the deep soft tissues of the thigh of an 81-year-old male with excellent neoadjuvant response to radiation. We briefly review treatment options.

14.
Int J Surg Pathol ; 24(8): 718-719, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27605089

ABSTRACT

Ductal spread (DS) of acinar adenocarcinoma of the prostate can lead to an incomplete replacement of the benign epithelium by cancer cells, resulting in a lesion that can be indistinguishable from high-grade prostatic intraepithelial neoplasia (HGPIN). Kovi and colleagues demonstrated 30 years ago that there is a significant association between the presence of DS and local extent of invasive adenocarcinoma, making the distinction between DS and HGPIN clinically relevant. However, despite the existence of certain morphologic features that are suggestive of DS, a definitive differentiation between the aforementioned lesions cannot always be attained.


Subject(s)
Carcinoma, Acinar Cell/diagnosis , Carcinoma, Ductal/diagnosis , Prostatic Intraepithelial Neoplasia/diagnosis , Prostatic Neoplasms/diagnosis , Carcinoma, Acinar Cell/pathology , Carcinoma, Ductal/pathology , Humans , Male , Neoplasm Grading , Prostatic Intraepithelial Neoplasia/pathology , Prostatic Neoplasms/pathology
15.
Appl Immunohistochem Mol Morphol ; 24(2): 144-8, 2016 Feb.
Article in English | MEDLINE | ID: mdl-25203429

ABSTRACT

The presence of benign epithelial inclusions in axillary lymph nodes coexistant with breast disease is a rare event; however, their presence makes the assessment of nodal disease diagnostically challenging. Broadly, these inclusions can be classified as glandular (müllerian type or nonmüllerian type), mixed glandular-squamous, and squamous. Among these the presence of benign müllerian-type glandular inclusions with concurrent breast parenchymal disease is an exceedingly rare event, with 10 previous cases reported in the literature, 2 coexisting with infiltrating ductal-type mammary carcinoma in axillary lymph nodes. Here, we report the first case of coexistent invasive lobular carcinoma and endosalpingiosis in an axillary lymph node.


Subject(s)
Breast Neoplasms/diagnosis , Carcinoma, Lobular/diagnosis , Epithelial Cells/pathology , Inclusion Bodies/pathology , Lymph Nodes/pathology , Lymphatic Metastasis/diagnosis , Mullerian Ducts/pathology , Neoplasms/diagnosis , Aged, 80 and over , Axilla , Biopsy , Breast Neoplasms/pathology , Carcinoma, Lobular/pathology , Female , Humans , Lymphatic Metastasis/pathology , Neoplasms/pathology
16.
Head Neck Pathol ; 10(2): 265-8, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26440804

ABSTRACT

Synchronous ipsilateral tumor formation within a major salivary gland is a very rare event. In this case, a 54-year-old female tobacco smoker presented with a slowly enlarging left parotid gland. Computed tomography of the neck demonstrated a solid mass superficial to a cystic mass in the deep lobe of the gland. Ultrasound-guided fine needle aspiration yielded oncocytic cells, lymphoid cells, and granular debris along with rare cohesive groups of basaloid cells. Parotidectomy was performed, and the resected gland was found to contain two adjacent but distinct masses. One mass, a predominantly solid, well-circumscribed lesion composed of ribbons of double-layered oncocytic cells and a lymphoid stroma with germinal center formation, was a Warthin tumor. The other mass, a predominantly cystic lesion composed of cords and nests of basaloid cells with associated deposits of basement membrane-like material, was a basal cell adenoma of the membranous type. To our knowledge, this is the first reported case of synchronous Warthin tumor and basal cell adenoma of the parotid gland with cytologic-histologic correlation attributable to each tumor.


Subject(s)
Adenolymphoma/pathology , Adenoma/pathology , Neoplasms, Multiple Primary/pathology , Parotid Neoplasms/pathology , Female , Humans , Middle Aged , Smoking
18.
J Vasc Interv Radiol ; 26(5): 723-32, 2015 May.
Article in English | MEDLINE | ID: mdl-25724086

ABSTRACT

PURPOSE: To perform a feasibility study to explore the relationship between hepatocellular carcinoma genetics and transarterial chemoembolization treatment response to identify potential biomarkers associated with enhanced treatment efficacy. MATERIALS AND METHODS: In this single-institution study, pretreatment hepatocellular carcinoma biopsy specimens for tumors in 19 patients (14 men, five women; mean age, 59 y) treated with chemoembolization between 2007 and 2013 were analyzed for a panel of 60 chemotherapy-sensitivity, hypoxia, mitosis, and inflammatory genes with the QuantiGene Plex 2.0 mRNA detection assay. Demographic, disease, and procedure data and tumor response outcomes were collected. Quantitative mRNA levels were compared based on radiologic response between tumors exhibiting complete response (CR) versus partial response (PR). RESULTS: The study sample included 19 biopsy specimens from tumors (mean size, 3.0 cm; grade 1, n = 6; grade 2, n = 9; grade 3, n = 4) in patients treated with a mean of two conventional chemoembolization sessions. Thirteen and six tumors exhibited CR and PR, respectively, at a mean of 116 days after treatment. Tumors with CR showed a significant increase in (P < .05) or trend toward (P < .1) greater (range, 1.49-3.50 fold) pretreatment chemotherapy-sensitivity and mitosis (ATF4, BAX, CCNE1, KIF11, NFX1, PPP3CA, SNX1, TOP2A, and TOP2B) gene mRNA expression compared with tumors with PR, in addition to lower CXCL10 levels (0.48-fold), and had significantly (P < .05) higher (1.65-fold) baseline VEGFA levels. CONCLUSIONS: Genetic signatures may allow prechemoembolization stratification of tumor response probability, and gene analysis may therefore offer an opportunity to personalize locoregional therapy by enhancing treatment modality allocation. Further corroboration of identified markers and exploration of their respective predictive capacity thresholds is necessary.


Subject(s)
Biomarkers/analysis , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic , Liver Neoplasms/genetics , Liver Neoplasms/therapy , Chemoembolization, Therapeutic/methods , Feasibility Studies , Female , Humans , Male , Middle Aged , Pilot Projects , Polymerase Chain Reaction
19.
Nucl Med Mol Imaging ; 49(1): 78-80, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25767629
20.
J Stroke Cerebrovasc Dis ; 24(1): e39-43, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25444026

ABSTRACT

Cerebral aspergillosis is a rare and highly fatal hematogenous infection most commonly found in immune compromised patients. From the onset of neurologic symptoms, the median reported rate of survival is between 5 and 9 days. Compounded with increased hemorrhagic risks and the lack of specificity in both clinical presentation and traditional imaging, a fast and noninvasive method of definitive diagnosis is necessary if there is to be any hope for positive outcomes. We describe the case of a 50-year-old female diabetic with a history of otitis media, an uncharacterized inflammatory nasopharyngeal process, and prior ischemic strokes who presented with a new cerebral infarction in the setting of an angioinvasive fungal infection of the large cerebral arteries. We also present a literature review of aspergillosis detection and treatment in hopes that future cases will be diagnosed in a timely manner and more patients may be saved.


Subject(s)
Brain Diseases/complications , Brain Ischemia/etiology , Diabetes Mellitus, Type 2/complications , Neuroaspergillosis/complications , Stroke/etiology , Brain Diseases/pathology , Brain Ischemia/pathology , Diabetes Mellitus, Type 2/pathology , Fatal Outcome , Female , Humans , Middle Aged , Neuroaspergillosis/pathology , Stroke/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...